Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Emdeki Utama Tbk. (MDKI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Emdeki Utama Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Emdeki Utama Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Emdeki Utama Tbk. trades at Rp190 (market cap 475.67B, 1.3K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume). The key difference: Emdeki Utama Tbk. is far larger — about 2.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (43.9K versus 1.3K). Which is the better fit depends on your goals.

MDKIOBAT
Market Cap
475.67B164.65B
Volume
1.3K43.9K
Lot
13439
Turnover
248.5K10.6M
Average Price
191.15241.43
Value
248.5K10.6M
Indicative Equilibrium Price
238
Indicative Equilibrium Volume
100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MDKI
View details
OBAT
View details

About Emdeki Utama Tbk.

PT Emdeki Utama (the Entity) was established based on Notarial Deed No. 33 of Hobropoerwanto, S.H., dated March 17, 1981.

Read more on MDKI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT